COVID-19 Impact on Global Insomnia Pharmacological Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 95 pages | ID: C79A1A5498A2EN
QYResearch

Abstracts

This report focuses on the global Insomnia Pharmacological Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Insomnia Pharmacological Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Eisai, Co. Ltd. (Japan)
• Merck & Co., Inc. (U.S.)
• Meda Consumer Healthcare Inc. (U.S.)
• Pfizer, Inc. (U.S.)
• Sanofi (France)
• Takeda Pharmaceutical Company Ltd. (Japan)
• Pernix Therapeutics (U.S.)
• Purdue Pharma L.P. (U.S.)

Market segment by Type, the product can be split into

• Prescription Sleep Aids
• Over-the-Counter Sleep Aids

Market segment by Application, split into

• Homecare
• Clinic
• Hospital

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Insomnia Pharmacological Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Insomnia Pharmacological Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Insomnia Pharmacological Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Insomnia Pharmacological Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Insomnia Pharmacological Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Prescription Sleep Aids
  1.4.3 Over-the-Counter Sleep Aids
1.5 Market by Application
  1.5.1 Global Insomnia Pharmacological Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Homecare
  1.5.3 Clinic
  1.5.4 Hospital
1.6 Coronavirus Disease 2019 (Covid-19): Insomnia Pharmacological Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Insomnia Pharmacological Treatment Industry
    1.6.1.1 Insomnia Pharmacological Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Insomnia Pharmacological Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Insomnia Pharmacological Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Insomnia Pharmacological Treatment Market Perspective (2015-2026)
2.2 Insomnia Pharmacological Treatment Growth Trends by Regions
  2.2.1 Insomnia Pharmacological Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Insomnia Pharmacological Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Insomnia Pharmacological Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Insomnia Pharmacological Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Insomnia Pharmacological Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Insomnia Pharmacological Treatment Players by Market Size
  3.1.1 Global Top Insomnia Pharmacological Treatment Players by Revenue (2015-2020)
  3.1.2 Global Insomnia Pharmacological Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Insomnia Pharmacological Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Insomnia Pharmacological Treatment Market Concentration Ratio
  3.2.1 Global Insomnia Pharmacological Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Insomnia Pharmacological Treatment Revenue in 2019
3.3 Insomnia Pharmacological Treatment Key Players Head office and Area Served
3.4 Key Players Insomnia Pharmacological Treatment Product Solution and Service
3.5 Date of Enter into Insomnia Pharmacological Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Insomnia Pharmacological Treatment Historic Market Size by Type (2015-2020)
4.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Type (2021-2026)

5 INSOMNIA PHARMACOLOGICAL TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Insomnia Pharmacological Treatment Market Size by Application (2015-2020)
5.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Insomnia Pharmacological Treatment Market Size (2015-2020)
6.2 Insomnia Pharmacological Treatment Key Players in North America (2019-2020)
6.3 North America Insomnia Pharmacological Treatment Market Size by Type (2015-2020)
6.4 North America Insomnia Pharmacological Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Insomnia Pharmacological Treatment Market Size (2015-2020)
7.2 Insomnia Pharmacological Treatment Key Players in Europe (2019-2020)
7.3 Europe Insomnia Pharmacological Treatment Market Size by Type (2015-2020)
7.4 Europe Insomnia Pharmacological Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Insomnia Pharmacological Treatment Market Size (2015-2020)
8.2 Insomnia Pharmacological Treatment Key Players in China (2019-2020)
8.3 China Insomnia Pharmacological Treatment Market Size by Type (2015-2020)
8.4 China Insomnia Pharmacological Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Insomnia Pharmacological Treatment Market Size (2015-2020)
9.2 Insomnia Pharmacological Treatment Key Players in Japan (2019-2020)
9.3 Japan Insomnia Pharmacological Treatment Market Size by Type (2015-2020)
9.4 Japan Insomnia Pharmacological Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Insomnia Pharmacological Treatment Market Size (2015-2020)
10.2 Insomnia Pharmacological Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Insomnia Pharmacological Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Insomnia Pharmacological Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Insomnia Pharmacological Treatment Market Size (2015-2020)
11.2 Insomnia Pharmacological Treatment Key Players in India (2019-2020)
11.3 India Insomnia Pharmacological Treatment Market Size by Type (2015-2020)
11.4 India Insomnia Pharmacological Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Insomnia Pharmacological Treatment Market Size (2015-2020)
12.2 Insomnia Pharmacological Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Insomnia Pharmacological Treatment Market Size by Type (2015-2020)
12.4 Central & South America Insomnia Pharmacological Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Eisai, Co. Ltd. (Japan)
  13.1.1 Eisai, Co. Ltd. (Japan) Company Details
  13.1.2 Eisai, Co. Ltd. (Japan) Business Overview and Its Total Revenue
  13.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Introduction
  13.1.4 Eisai, Co. Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2015-2020))
  13.1.5 Eisai, Co. Ltd. (Japan) Recent Development
13.2 Merck & Co., Inc. (U.S.)
  13.2.1 Merck & Co., Inc. (U.S.) Company Details
  13.2.2 Merck & Co., Inc. (U.S.) Business Overview and Its Total Revenue
  13.2.3 Merck & Co., Inc. (U.S.) Insomnia Pharmacological Treatment Introduction
  13.2.4 Merck & Co., Inc. (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
  13.2.5 Merck & Co., Inc. (U.S.) Recent Development
13.3 Meda Consumer Healthcare Inc. (U.S.)
  13.3.1 Meda Consumer Healthcare Inc. (U.S.) Company Details
  13.3.2 Meda Consumer Healthcare Inc. (U.S.) Business Overview and Its Total Revenue
  13.3.3 Meda Consumer Healthcare Inc. (U.S.) Insomnia Pharmacological Treatment Introduction
  13.3.4 Meda Consumer Healthcare Inc. (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
  13.3.5 Meda Consumer Healthcare Inc. (U.S.) Recent Development
13.4 Pfizer, Inc. (U.S.)
  13.4.1 Pfizer, Inc. (U.S.) Company Details
  13.4.2 Pfizer, Inc. (U.S.) Business Overview and Its Total Revenue
  13.4.3 Pfizer, Inc. (U.S.) Insomnia Pharmacological Treatment Introduction
  13.4.4 Pfizer, Inc. (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
  13.4.5 Pfizer, Inc. (U.S.) Recent Development
13.5 Sanofi (France)
  13.5.1 Sanofi (France) Company Details
  13.5.2 Sanofi (France) Business Overview and Its Total Revenue
  13.5.3 Sanofi (France) Insomnia Pharmacological Treatment Introduction
  13.5.4 Sanofi (France) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
  13.5.5 Sanofi (France) Recent Development
13.6 Takeda Pharmaceutical Company Ltd. (Japan)
  13.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Company Details
  13.6.2 Takeda Pharmaceutical Company Ltd. (Japan) Business Overview and Its Total Revenue
  13.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Introduction
  13.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
  13.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Recent Development
13.7 Pernix Therapeutics (U.S.)
  13.7.1 Pernix Therapeutics (U.S.) Company Details
  13.7.2 Pernix Therapeutics (U.S.) Business Overview and Its Total Revenue
  13.7.3 Pernix Therapeutics (U.S.) Insomnia Pharmacological Treatment Introduction
  13.7.4 Pernix Therapeutics (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
  13.7.5 Pernix Therapeutics (U.S.) Recent Development
13.8 Purdue Pharma L.P. (U.S.)
  13.8.1 Purdue Pharma L.P. (U.S.) Company Details
  13.8.2 Purdue Pharma L.P. (U.S.) Business Overview and Its Total Revenue
  13.8.3 Purdue Pharma L.P. (U.S.) Insomnia Pharmacological Treatment Introduction
  13.8.4 Purdue Pharma L.P. (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
  13.8.5 Purdue Pharma L.P. (U.S.) Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Insomnia Pharmacological Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Insomnia Pharmacological Treatment Revenue
Table 3. Ranking of Global Top Insomnia Pharmacological Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Insomnia Pharmacological Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Prescription Sleep Aids
Table 6. Key Players of Over-the-Counter Sleep Aids
Table 7. COVID-19 Impact Global Market: (Four Insomnia Pharmacological Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Insomnia Pharmacological Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Insomnia Pharmacological Treatment Players to Combat Covid-19 Impact
Table 12. Global Insomnia Pharmacological Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Insomnia Pharmacological Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Insomnia Pharmacological Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Insomnia Pharmacological Treatment Market Share by Regions (2015-2020)
Table 16. Global Insomnia Pharmacological Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Insomnia Pharmacological Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Insomnia Pharmacological Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Insomnia Pharmacological Treatment Players
Table 23. Global Insomnia Pharmacological Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Insomnia Pharmacological Treatment Market Share by Players (2015-2020)
Table 25. Global Top Insomnia Pharmacological Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Pharmacological Treatment as of 2019)
Table 26. Global Insomnia Pharmacological Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Insomnia Pharmacological Treatment Product Solution and Service
Table 29. Date of Enter into Insomnia Pharmacological Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Insomnia Pharmacological Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Insomnia Pharmacological Treatment Market Size Share by Type (2015-2020)
Table 33. Global Insomnia Pharmacological Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Insomnia Pharmacological Treatment Market Size Share by Application (2015-2020)
Table 35. Global Insomnia Pharmacological Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Insomnia Pharmacological Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Insomnia Pharmacological Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Insomnia Pharmacological Treatment Market Share (2019-2020)
Table 39. North America Insomnia Pharmacological Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Insomnia Pharmacological Treatment Market Share by Type (2015-2020)
Table 41. North America Insomnia Pharmacological Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Insomnia Pharmacological Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Insomnia Pharmacological Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Insomnia Pharmacological Treatment Market Share (2019-2020)
Table 45. Europe Insomnia Pharmacological Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Insomnia Pharmacological Treatment Market Share by Type (2015-2020)
Table 47. Europe Insomnia Pharmacological Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Insomnia Pharmacological Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Insomnia Pharmacological Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Insomnia Pharmacological Treatment Market Share (2019-2020)
Table 51. China Insomnia Pharmacological Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Insomnia Pharmacological Treatment Market Share by Type (2015-2020)
Table 53. China Insomnia Pharmacological Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Insomnia Pharmacological Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Insomnia Pharmacological Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Insomnia Pharmacological Treatment Market Share (2019-2020)
Table 57. Japan Insomnia Pharmacological Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Insomnia Pharmacological Treatment Market Share by Type (2015-2020)
Table 59. Japan Insomnia Pharmacological Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Insomnia Pharmacological Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Insomnia Pharmacological Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Insomnia Pharmacological Treatment Market Share (2019-2020)
Table 63. Southeast Asia Insomnia Pharmacological Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Insomnia Pharmacological Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Insomnia Pharmacological Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Insomnia Pharmacological Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Insomnia Pharmacological Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Insomnia Pharmacological Treatment Market Share (2019-2020)
Table 69. India Insomnia Pharmacological Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Insomnia Pharmacological Treatment Market Share by Type (2015-2020)
Table 71. India Insomnia Pharmacological Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Insomnia Pharmacological Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Insomnia Pharmacological Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Insomnia Pharmacological Treatment Market Share (2019-2020)
Table 75. Central & South America Insomnia Pharmacological Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Insomnia Pharmacological Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Insomnia Pharmacological Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Insomnia Pharmacological Treatment Market Share by Application (2015-2020)
Table 79. Eisai, Co. Ltd. (Japan) Company Details
Table 80. Eisai, Co. Ltd. (Japan) Business Overview
Table 81. Eisai, Co. Ltd. (Japan) Product
Table 82. Eisai, Co. Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2015-2020) (Million US$)
Table 83. Eisai, Co. Ltd. (Japan) Recent Development
Table 84. Merck & Co., Inc. (U.S.) Company Details
Table 85. Merck & Co., Inc. (U.S.) Business Overview
Table 86. Merck & Co., Inc. (U.S.) Product
Table 87. Merck & Co., Inc. (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020) (Million US$)
Table 88. Merck & Co., Inc. (U.S.) Recent Development
Table 89. Meda Consumer Healthcare Inc. (U.S.) Company Details
Table 90. Meda Consumer Healthcare Inc. (U.S.) Business Overview
Table 91. Meda Consumer Healthcare Inc. (U.S.) Product
Table 92. Meda Consumer Healthcare Inc. (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020) (Million US$)
Table 93. Meda Consumer Healthcare Inc. (U.S.) Recent Development
Table 94. Pfizer, Inc. (U.S.) Company Details
Table 95. Pfizer, Inc. (U.S.) Business Overview
Table 96. Pfizer, Inc. (U.S.) Product
Table 97. Pfizer, Inc. (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020) (Million US$)
Table 98. Pfizer, Inc. (U.S.) Recent Development
Table 99. Sanofi (France) Company Details
Table 100. Sanofi (France) Business Overview
Table 101. Sanofi (France) Product
Table 102. Sanofi (France) Revenue in Insomnia Pharmacological Treatment Business (2015-2020) (Million US$)
Table 103. Sanofi (France) Recent Development
Table 104. Takeda Pharmaceutical Company Ltd. (Japan) Company Details
Table 105. Takeda Pharmaceutical Company Ltd. (Japan) Business Overview
Table 106. Takeda Pharmaceutical Company Ltd. (Japan) Product
Table 107. Takeda Pharmaceutical Company Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2015-2020) (Million US$)
Table 108. Takeda Pharmaceutical Company Ltd. (Japan) Recent Development
Table 109. Pernix Therapeutics (U.S.) Company Details
Table 110. Pernix Therapeutics (U.S.) Business Overview
Table 111. Pernix Therapeutics (U.S.) Product
Table 112. Pernix Therapeutics (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020) (Million US$)
Table 113. Pernix Therapeutics (U.S.) Recent Development
Table 114. Purdue Pharma L.P. (U.S.) Business Overview
Table 115. Purdue Pharma L.P. (U.S.) Product
Table 116. Purdue Pharma L.P. (U.S.) Company Details
Table 117. Purdue Pharma L.P. (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020) (Million US$)
Table 118. Purdue Pharma L.P. (U.S.) Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Insomnia Pharmacological Treatment Market Share by Type: 2020 VS 2026
Figure 2. Prescription Sleep Aids Features
Figure 3. Over-the-Counter Sleep Aids Features
Figure 4. Global Insomnia Pharmacological Treatment Market Share by Application: 2020 VS 2026
Figure 5. Homecare Case Studies
Figure 6. Clinic Case Studies
Figure 7. Hospital Case Studies
Figure 8. Insomnia Pharmacological Treatment Report Years Considered
Figure 9. Global Insomnia Pharmacological Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Insomnia Pharmacological Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Insomnia Pharmacological Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Insomnia Pharmacological Treatment Market Share by Players in 2019
Figure 14. Global Top Insomnia Pharmacological Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Pharmacological Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Insomnia Pharmacological Treatment Revenue in 2019
Figure 16. North America Insomnia Pharmacological Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Insomnia Pharmacological Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Insomnia Pharmacological Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Insomnia Pharmacological Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Insomnia Pharmacological Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Insomnia Pharmacological Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Insomnia Pharmacological Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Eisai, Co. Ltd. (Japan) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Eisai, Co. Ltd. (Japan) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2015-2020)
Figure 25. Merck & Co., Inc. (U.S.) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Merck & Co., Inc. (U.S.) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2015-2020)
Figure 27. Meda Consumer Healthcare Inc. (U.S.) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Meda Consumer Healthcare Inc. (U.S.) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2015-2020)
Figure 29. Pfizer, Inc. (U.S.) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer, Inc. (U.S.) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2015-2020)
Figure 31. Sanofi (France) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sanofi (France) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2015-2020)
Figure 33. Takeda Pharmaceutical Company Ltd. (Japan) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Takeda Pharmaceutical Company Ltd. (Japan) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2015-2020)
Figure 35. Pernix Therapeutics (U.S.) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Pernix Therapeutics (U.S.) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2015-2020)
Figure 37. Purdue Pharma L.P. (U.S.) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Purdue Pharma L.P. (U.S.) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed